Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma

BACKGROUND: Esophageal squamous cell cancer (ESCC) patients with the potentially resectable disease most would experience relapse after surgery. Immunotherapy has been reported to improve the prognosis of advanced esophageal cancer and may be a new strategy to prevent this urgent condition’s recurre...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Thorac Dis
Autori principali: Wu, Zhigang, Zheng, Qiang, Chen, Haiquan, Xiang, Jiaqing, Hu, Hong, Li, Hang, Pan, Yunjian, Peng, Yizhou, Yao, Xingxin, Liu, Pengcheng, Sun, Yihua, Li, Bin, Zhang, Yawei
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2021
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264718/
https://ncbi.nlm.nih.gov/pubmed/34277047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-21-340
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi